Delivery Order SPE2DR25D2104-SPE2DR26F3PEF
- Not listed
- The Defense Logistics Agency awarded a $1,682.50 delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for Epidiolex 100 mg/ml solution in 100 ml packs, with a completion date of October 29, 2025. This competitively awarded, firm fixed-price order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order valued at $8,412.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/mL solution in 100 mL packs, with an ultimate completion date of November 28, 2025. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's medical supply needs,...
- The Defense Logistics Agency awarded a $1,682.50 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epidiolex 100 mg/ml solution in a 100 ml pack. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,412.50 on August 29, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,280.92 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with an ultimate completion date of October 6, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol medication used primarily for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,190.00 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. The contract is a firm fixed price delivery order with an ultimate completion date of October 20, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,720.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 milliliters of Epidiolex 100 mg/ml solution on November 5, 2025, with completion targeted for November 28, 2025. This is a non-set-aside delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the company's...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, valued at $1,280.92 with a firm fixed price contract type. The award was not set aside for small businesses or other designated groups and carries an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a $1,349.88 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs. This is a firm fixed-price, non-set-aside contract with a completion date of December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol-based medication primarily used for the treatment of seizure disorders, particularly in pediatric...
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packaging, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside transaction and leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PEFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,546.20 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs on November 17, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The company's federal contract awards demonstrate its capability to meet DLA requirements for diverse pharmaceutical needs, ranging from specialty neurological and pain management medications to routine medical commodities. This particular delivery order for Epidiolex, a cannabidiol-based pharmaceutical used for seizure management, reflects the breadth of therapeutic products the company supplies to support Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 11/17/25 |